JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
NB Bancorp
NBBK
$1.01B
| $3.71M | ﹤0.01% |
199,804
+108,774
| +119% | +$1.92M |
|
3327
Burford Capital
BUR
$960M
| $3.71M | ﹤0.01% |
279,427
+30,355
| +12% | +$403K |
|
3328
WisdomTree US High Dividend Fund
DHS
$1.6B
| $3.7M | ﹤0.01% |
39,446
+1,323
| +3% | +$119K |
|
3329
CALL
Abercrombie & Fitch
ANF
$4.8B
| $3.69M | ﹤0.01% |
26,400
+1,400
| +6% | +$213K |
|
3330
Aurinia Pharmaceuticals
AUPH
$2.06B
| $3.69M | ﹤0.01% |
502,816
-4,218
| -0.8% | -$26.2K |
|
3331
CALL
Biogen
BIIB
$31B
| $3.68M | ﹤0.01% |
19,000
| – | – |
|
3332
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $3.68M | ﹤0.01% |
80,462
+20,155
| +33% | +$910K |
|
3333
Horace Mann Educators
HMN
$2.13B
| $3.67M | ﹤0.01% |
105,027
-20,438
| -16% | -$698K |
|
3334
Kaiser Aluminum
KALU
$2.97B
| $3.67M | ﹤0.01% |
50,551
-5,179
| -9% | -$398K |
|
3335
SiTime
SITM
$21.4B
| $3.66M | ﹤0.01% |
21,365
-13,553
| -39% | -$1.94M |
|
3336
CALL
The GEO Group
GEO
$4.11B
| $3.66M | ﹤0.01% |
+284,900
| New | +$3.97M |
|
3337
Lands' End
LE
$384M
| $3.66M | ﹤0.01% |
211,916
+69,099
| +48% | +$1.07M |
|
3338
Algoma Steel
ASTL
$452M
| $3.66M | ﹤0.01% |
357,367
+49,642
| +16% | +$457K |
|
3339
Dyne Therapeutics
DYN
$4.8B
| $3.65M | ﹤0.01% |
101,750
+4,236
| +4% | +$169K |
|
3340
TPG
TPG
$8.51B
| $3.65M | ﹤0.01% |
63,449
+17,709
| +39% | +$872K |
|
3341
DHT Holdings
DHT
$3.15B
| $3.65M | ﹤0.01% |
331,048
-919,624
| -74% | -$10.1M |
|
3342
VTEX
VTEX
$618M
| $3.65M | ﹤0.01% |
490,234
+116,895
| +31% | +$813K |
|
|
WBND
3343
DELISTED
Western Asset Total Return ETF
WBND
| $3.64M | ﹤0.01% |
175,293
-139,216
| -44% | -$2.85M |
|
3344
BNY Mellon Concentrated International ETF
BKCI
$134M
| $3.64M | ﹤0.01% |
67,856
+7,401
| +12% | +$386K |
|
3345
Invesco BuyBack Achievers ETF
PKW
$1.8B
| $3.64M | ﹤0.01% |
31,781
+582
| +2% | +$63K |
|
3346
CALL
Voya Financial
VOYA
$9.2B
| $3.64M | ﹤0.01% |
45,900
| – | – |
|
|
3347
PUT
Voya Financial
VOYA
$9.2B
| $3.64M | ﹤0.01% |
45,900
| – | – |
|
3348
First Trust Capital Strength ETF
FTCS
$8.02B
| $3.63M | ﹤0.01% |
40,027
-555,606
| -93% | -$48.7M |
|
3349
iShares US Healthcare Providers ETF
IHF
$1.27B
| $3.62M | ﹤0.01% |
63,426
-3,322
| -5% | -$185K |
|
3350
OraSure Technologies
OSUR
$265M
| $3.62M | ﹤0.01% |
847,933
+46,216
| +6% | +$199K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.